# Mike Ravenscroft

> Mike Ravenscroft is a Series A investor at Dingman Center for Entrepreneurship backing Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Dingman Center for Entrepreneurship](https://shizune.co/investors/profile/dingman-center-angels)
- Location: Washington, United States
- Total investments: 5
- Last investment: Jan 2025
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/michael-ravenscroft/77/ba8/85a

Mike Ravenscroft is a Series A investor at Dingman Center for Entrepreneurship in Washington focused on Health Care and AgTech. Mike manages the day-to-day operations of the PeaceTech Accelerator in Washington, D.C. and oversees C5 Accelerate’s domestic portfolio of early stage investments. In this capacity, he works with C5’s network of mentors, partners, and investors to help its network of entrepreneurs scale their businesses. Prior to joining C5, Mike was Director ofthe MACH37 Cyber Accelerator and was on the Investment Team at CIT GAP Funds, a non-profit venture capital fund in Herndon, VA. While at CIT, Mike helped launch the EMERGE accelerator program on behalf of the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and Smart City Works, an accelerator for early stage companies developing technology for the built environment. Mike began his career as a Research Associate at The Advisory Board Company in Washington, D.C. He holds a BA from the University of Michigan and an MA from American University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| AgTech | 1 | 20% |
| Travel | 1 | 20% |
| Leisure | 1 | 20% |
| Tourism | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Impruvon Health | Impruvon Health is on a mission to improve the health of individuals with difficult to maintain medication regimens, living at home or in long-term care environments as well as the lives of those supporting them. They have worked extremely hard to tailor our solution to specific groups of individuals including those living with intellectualand/or developmental disabilities, those undergoing recovery from an addiction, and veterans Their platform automates medication management by eliminating the manual storage and administration processes as well as record keeping while aiding independence and security for the individual prescribed. Having experienced the detrimental impacts that medication errors can have on an individual and their family firsthand has given us a unique understanding of the technology required to stop errors, thefts, and overdoses while aiding medication compliance for individuals and their loved ones. | $2.4M | Seed | Jan 28, 2025 |  |
| Minnowtech | Minnowtech is an aquaculture technology company, based in Baltimore, MD, that provides a software imaging platform to enable shrimp farmers to estimate shrimp abundance non-invasively with precision. Using Minnowtech’s data-based imaging tool, shrimp farmers optimize the health and growth of their hatcheries, enhancing the harvest of market-sizeshrimp while minimizing risks to juvenile shrimp. With the continued growth of aquaculture worldwide, Minnowtech addresses head-on the industry’s most acute challenge, which is overcoming limitations in how shrimp farmers assess the abundance, growth, and optimal harvest times of their crop. Minnowtech, via its low-cost technology and expert team of marine scientists, helps improve aquaculture farmers’ livelihoods while improving global food security and sustainability of marine environments. |  | Series A | Feb 26, 2024 |  |
| Linshom Medical, Inc. | Linshom is first to deliver continuous respiratory monitoring, including Tidal Volume, to the patient bedside. | $2.2M | Series A | Aug 15, 2023 |  |
| Astek Diagnostics | Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria | $2M | Seed | Jun 05, 2023 |  |
| Marinalife | Marinalife provides premium content and valuable services for all types of boaters. The Marinalife Cruising Club membership offers boaters access to detailed marina information, travel resources including trip itineraries and destination guides to make their next boating adventure stress-free. In addition, the Marinalife magazine, a quarterlytravel and lifestyle publication, provides boaters with entertaining and useful articles about destinations, marinas, cruising stories, captain's tips and more. |  | Series A | Jan 25, 2023 |  |

5 of 5 investments shown.

## Co-investors
- [TEDCO](https://shizune.co/investors/profile/maryland-technology-development-corporation) — VC Fund, 5 deals together
- [Abell Foundation](https://shizune.co/investors/profile/abell-foundation) — VC Fund, 4 deals together
- [Propel Baltimore Fund](https://shizune.co/investors/profile/propel-baltimore-fund) — VC Fund, 3 deals together
- [Ayana capital](https://shizune.co/investors/profile/ayana-capital) — VC Fund, 1 deal together
- [Claritas Capital](https://shizune.co/investors/profile/claritas-capital) — VC Fund, 1 deal together
- [Desert Angels](https://shizune.co/investors/profile/desert-angels) — VC Fund, 1 deal together

## About Dingman Center for Entrepreneurship

VC Fund · College Park, United States

The Dingman Center Angels is a Maryland based angel investment group that provides funding to early-stage companies.

4 contacts available at Dingman Center for Entrepreneurship.

| Name | Title | Profile |
| --- | --- | --- |
| Alla Corey | Program Manager | https://shizune.co/investors/profile/alla-corey |
| Rudolph P. Lamone | Founder | https://shizune.co/investors/profile/dr-rudolph-p-lamone |
| Brent Goldfarb | Academic Director | https://shizune.co/investors/profile/brent-goldfarb |
| Mike Ravenscroft | Venture Associate | https://shizune.co/investors/profile/mike-ravenscroft |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Mike Ravenscroft invest in?

Mike Ravenscroft invests primarily in Health Care, AgTech and Travel startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mike Ravenscroft last invest?

The most recent investment recorded for Mike Ravenscroft closed in Jan 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co